Oak Grove Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Oak Grove Capital's LLY Position: Q1 2026 in Review
Oak Grove Capital increased its Eli Lilly (LLY) stake by 0.35% in Q1 2026, buying an estimated $72K and bringing the position to 20,441 shares worth $18.8M. The position accounts for 1.59% of the portfolio, ranked #13.
Oak Grove Capital first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $78M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Oak Grove Capital held 20,441 shares of Eli Lilly worth $18.8M as of Q1 2026.
- Oak Grove Capital bought 71 Eli Lilly shares in Q1 2026, an estimated $72K.
- Eli Lilly made up 1.59% of Oak Grove Capital's portfolio in Q1 2026, its #13 holding.
- Oak Grove Capital first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
- Oak Grove Capital's Eli Lilly position peaked at $78M in Q3 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Oak Grove Capital's 13F filing for Q1 2026, filed 13 May 2026.